| |
|
|
| Name: |
SUVRETTA CAPITAL MANAGEMENT LLC |
| City: |
New York |
| State: |
NY |
| Zip: |
10022 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
27 |
|
View All Holdings |
Currently
Viewing:
Increased Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
BHVN |
Biohaven Ltd. |
1 |
- |
$40.69 |
$195,717,000 |
4,572,836 |
8.95% |
91,531,000 |
567,236 |
6.709 |
N/A |
|
|
RARE |
Ultragenyx Pharmaceutical Inc |
4 |
- |
$42.75 |
$101,680,000 |
2,126,306 |
4.65% |
77,457,000 |
1,446,847 |
3.12 |
Restaurants |
|
|
EYPT |
EyePoint Pharmaceuticals Inc |
6 |
- |
$0.44 |
$93,754,000 |
4,056,847 |
4.29% |
65,852,000 |
564,700 |
2.827 |
Biotechnology |
|
|
MRNS |
Marinus Pharmaceuticals Inc |
11 |
- |
$1.51 |
$58,112,000 |
5,346,119 |
2.66% |
16,212,000 |
141,177 |
10.774 |
N/A |
|
|
ETNB |
89bio, Inc. |
13 |
- |
$9.22 |
$54,604,000 |
4,888,434 |
2.5% |
13,002,000 |
2,194,030 |
6.561 |
N/A |
|
|
APO |
Apollo Global Management LLC |
14 |
- |
$109.46 |
$50,399,000 |
540,820 |
2.3% |
33,174,000 |
348,920 |
0.09 |
Diversified Investments |
|
|
GE |
General Electric Co |
16 |
- |
$164.11 |
$45,459,000 |
356,180 |
2.08% |
6,659,000 |
5,211 |
0.032 |
Conglomerates |
|
|
GS |
Goldman Sachs Group Inc |
17 |
- |
$438.18 |
$42,554,000 |
110,310 |
1.95% |
42,554,000 |
110,310 |
0.032 |
Investment Brokerage ... |
|
|
TSM |
Taiwan Semiconductor Mfg. C... |
18 |
- |
$141.56 |
$40,376,000 |
388,232 |
1.85% |
40,376,000 |
388,232 |
0.007 |
Semiconductor - Integ... |
|
|
BSX |
Boston Scientific Corp |
19 |
- |
$72.85 |
$40,126,000 |
694,101 |
1.83% |
21,448,000 |
340,360 |
0.049 |
Medical Instruments &... |
|
|
LVS |
Las Vegas Sands Corp |
22 |
- |
$46.87 |
$36,325,000 |
738,163 |
1.66% |
6,858,000 |
95,330 |
0.097 |
Gambling/Resorts |
|
|
ORCL |
Oracle Corp |
24 |
- |
$115.80 |
$33,954,000 |
322,050 |
1.55% |
6,911,000 |
66,739 |
0.011 |
Application Software |
|
|
KALV |
Kalvista Pharmaceuticals Inc |
25 |
- |
$12.13 |
$32,879,000 |
2,684,005 |
1.5% |
9,566,000 |
263,154 |
7.95 |
N/A |
|
|
MCK |
McKesson Corp |
26 |
- |
$531.10 |
$29,381,000 |
63,460 |
1.34% |
13,057,000 |
25,920 |
0.039 |
Drugs Wholesale |
|
|
CI |
Cigna Corporation |
27 |
- |
$341.50 |
$28,837,000 |
96,300 |
1.32% |
27,693,000 |
92,300 |
0.026 |
Health Care Plans |
|
|
ARQT |
Arcutis Biotherapeutics, Inc. |
28 |
- |
$8.00 |
$27,368,000 |
8,473,101 |
1.25% |
21,340,000 |
7,337,874 |
11.281 |
N/A |
|
|
ANTM |
Anthem Inc |
30 |
- |
$526.96 |
$25,339,000 |
53,735 |
1.16% |
24,028,000 |
50,725 |
0.021 |
N/A |
|
|
COGT |
Cogent Biosciences, Inc. |
32 |
- |
$7.53 |
$21,818,000 |
3,710,539 |
1% |
-7,952,000 |
657,239 |
4.692 |
N/A |
|
|
ARGX |
Argenx Se |
34 |
- |
$388.20 |
$20,429,000 |
53,700 |
0.93% |
19,052,000 |
50,900 |
0.114 |
N/A |
|
|
RCUS |
Arcus Biosciences Inc |
37 |
- |
$15.70 |
$18,285,000 |
957,304 |
0.84% |
7,567,000 |
360,205 |
1.475 |
N/A |
|
|
MREO |
Mereo Biopharma Group plc |
38 |
- |
$3.26 |
$17,027,000 |
7,370,838 |
0.78% |
7,527,000 |
6,400 |
6.809 |
N/A |
|
|
ELAN |
Elanco Animal Health Inc |
44 |
- |
$13.53 |
$9,153,000 |
614,300 |
0.42% |
3,123,000 |
77,800 |
0.125 |
N/A |
|
|
SNY |
Sanofi Aventis (ADR) |
46 |
- |
$49.01 |
$8,504,000 |
171,001 |
0.39% |
2,280,000 |
54,960 |
0.007 |
Drug Manufacturers - ... |
|
|
PROK |
Prokidney Ord Shs Class A |
48 |
- |
$9.28 |
$6,885,000 |
3,867,847 |
0.31% |
-10,830,000 |
4 |
10.644 |
N/A |
|
|
ABT |
Abbott Laboratories |
57 |
- |
$105.90 |
$3,690,000 |
33,520 |
0.17% |
1,693,000 |
12,900 |
0.002 |
Drug Manufacturers - ... |
|
|
CRL |
Charles River Laboratories ... |
86 |
- |
$233.47 |
$239,000 |
1,010 |
0.01% |
239,000 |
1,010 |
0.002 |
Biotechnology |
|
|
TECH |
Techne Corp |
87 |
- |
$77.29 |
$201,000 |
2,600 |
0.01% |
201,000 |
2,600 |
0.002 |
Biotechnology |
|
